Sinovac, AstraZeneca Covid-19 vaccines given conditional approval for use as boosters

PETALING JAYA: The Drug Control Authority (DCA) has given conditional approval to the Covid-19 vaccines from Sinovac and AstraZeneca as booster shots, says the Health Ministry.

In a statement on Wednesday (Nov 17), Health director-general Tan Sri Dr Noor Hisham Abdullah said approval had been given for the two vaccines to be used as booster doses for individuals aged 18 years and above who had received vaccines of the same type (homologous).

"The booster vaccine for AstraZeneca will be administered six months from when the second dose was given, whilst for CoronaVac, the booster dose will be administered three to six months after the second dose," Dr Noor Hisham added.

The administration of the booster doses for both varieties of vaccine to targeted groups will be outlined by the Covid-19 Immunisation Booster Task Force (CITF-B) and announced from time to time.

He said the Health Ministry would like to emphasise that the conditional registration approval required information on quality, safety and efficacy of the vaccines to be monitored and evaluated, in accordance with the latest data.

"This is to ensure the comparison of benefits over risk of the vaccines remain positive," said Dr Noor Hisham.

He added the ministry was committed in upgrading the access of Covid-19 vaccine products in the country.

Meanwhile a tweet on Wednesday, Health Minister Khairy Jamaluddin said this would allow the Vaccination Technical Working Group to make recommendations on who could receive the shot under the heterologous booster programme.

Sinovac and AZ boosters have gotten regulatory approval today which paves way for the Vaccination Technical Working Group to make recommendations on who qualifies to receive & the vaccines’ inclusion for the heterologous booster programme. https://t.co/dqtKC6L6m2 — Khairy Jamaluddin